The mechanism of signal transduction during vascular smooth muscle cell proliferation induced by autoantibodies against angiotensin AT1 receptor from hypertension

Chinese Medical Journal

Volumn 121, Issue 1, 2008, Pages 43-48

  Sun, Yan Xiang ^a   Zhang, Hai Yan ^a   Wei, Yu Miao ^a   Zhu, Feng ^a   Wang, Min ^a   Liao, Yu Hua ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Activation of transcription; Angiotensin AT1 receptor; Autoantibody; Janus kinase signal transduction; nuclear factor B; Proliferation

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN II; AUTOANTIBODY; BROXURIDINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; JANUS KINASE 2; LOSARTAN; N BENZYL 2 CYANO 3 (3,4 DIHYDROXYPHENYL)ACRYLAMIDE; PYRROLIDINE DITHIOCARBAMATE; RECEPTOR ANTIBODY; STAT1 PROTEIN; STAT3 PROTEIN;

AFFINITY CHROMATOGRAPHY; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DENSITY; ENZYME PHOSPHORYLATION; GEL MOBILITY SHIFT ASSAY; HYPERTENSION; IMMUNOPATHOGENESIS; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE; WESTERN BLOTTING;

EID: 38349118311     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00029330-200801010-00009     Document Type: Article

References (23)

1. Dzielak D. The immune system and hypertension. Hypertension 1992; 19: 136-144.
2. Khraibi AA. Immunoregulatory failure in the pathophysiology of hypertension. News Physiol Sci 1994; 9: 27-30.
3. Fu ML, Herlitz H, Wallukat G, Hilme E, Hedner T, Hoebeke J, et al. Non-desensitized positive chronotropic effect of anti-angiotension II receptor autoantibodies in a patient with malignant hypertension. Circulation 1996; 94: 4046a.
4. Wallukat Q Homuth V, Fischer T, Lindschau C, Horstkamp B, Jüpner A, et al. Patients with preeclampsia develop agonistic antibodies against the añgiotension AT1 receptor. J Clin Invest 1999; 1103: 945-952.
5. Liao YH, Wei YM, Wang6 M, Wang ZH, Yuan HT, Cheng LX. Autoantibodies against AT1-receptor and alpha1-adrenergic receptor in patients with hypertension. Hypertens Res 2002; 25: 641-646.
6. Fu ML, Leung PS, Wallukat G, Bergstrom G, Fu H, Schulze W, et al. Agonist-like activity of antibodies to angiotensin II receptor subtype1 (AT1) from rats immunized with AT1 receptor peptide. Blood Press 1999; 8: 317-324.
7. Fu ML, Herlitz H, Schulze W, Wallukat G, Micke P, Eftekhari P, et al. Autoantibodies against the angiotensin receptor (AT1) in patients with hypertension. J Hypertens 2000; 18: 945-953.
8. Zhi JM, Zhao LY, Jiao XY, Zhao RR. Changes in autoantibodies against cardiovascular AT1-receptor during development of renovascular hypertension in rats. Acta Physiologica Sinica, (Chin) 2002; 54: 317-320.
9. Wang B, Liao YH, Zhou ZH, Li LD, Wei F, Wang M, et al. Arterial structure changes in rats immunized by AT1-receptor peptide. Heart Vessels 2005; 20: 153-158.
10. Marrero MB, Schiefferi B, Li B, Sun J, Harp JB, Ling BN. Role of Janus Kinase/signal transducer and activator of transcription and mitogen-activated protein kinase cascades in angiotensin II and platelet-derived growth factor-induced vascular smooth muscle cell proliferation. J Biol Chem 1997; 272: 24684-24690.
11. Mario BM, Bernhard S, William GP, LaurI H, Bradford CB, Patrick D, et al. Direct stimulation of Jak/Stat pathway by the angiontension II AT1 receptor. Nature 1995; 375: 247-250.
12. Zahradka P, Werner JF, Buhay S, Litchie B, Helwer G, Thomas S. NF-κB activation is essential for angiotensin II-dependent proliferation'and migration of vascular smooth muscle cells. J Mol Cell Cardiol 2002; 34: 1609-1621.
13. 1-adrenergic receptor in rats. Clin Immunol 2005; 114: 164-173.
14. Ma YW, Zhang LP, Peng T, Cheng JZ, Shilpa T, Zhang JQ. Angiotensin II stimulates transcription of insulin-like growth factor 1 receptor in vascular smooth muscle cells: role of NF-κB. Endocrinology 2006; 147: 1256-1263.
15. Sun YX, Wei YM, Liao YH, Zhang HY, Zhu F, Wang M, et al. Participation of NF-κB and Janus kinase signal transductors and activation of transcription pathway in rat VSMCs proliferation effect mediated by Ang II. Chin J Hypertension (Chin) 2006; 14: 477-482.
16. Briscoe J, Guschin D, Muller M. Signal transduction, just another signaling pathway Curr Biol 1994; 4: 1033-1035.
17. Ziemiccki A, Harpur AG, Wilks AF. JAK protein tyrosine kinases: their role in cytokine signaling. Trends Cell Biol 1994; 4: 207-212.
18. Briscoe J, Kohlhuber F, Mullerz M. JAKs and STATs branch out. Trends Cell Biol 1996; 6: 336-340.
19. Yamamoto H, Crow M, Cheung L, Lakatta E, Kinsella J. PDGF receptor-to-nucleus signaling of p91 (STAT1 alpha) transcription factor in rat smooth muscle cells. Exp Cell Res 1996; 222: 125-130.
20. Liao YH, Wei YM, Wang M, Dong JH, Wang ZhH, Yuan HT. Effect of autoantibodies against AT1 receptor autoantibodies and angiotensin II on refractory hypertension. South China J Cardiol (Chin) 2001; 2: 65-67.
21. Kim OS, Park EJ Joe EH, Jou I. JAK-STAT -signaling mediates gangliosides-induced inflammatory responses in brain microglial cells. J Diol Chem 2002; 277:40594-40601.
22. Volkhard, L. The NF-κB and I B system in injured arteries. Pathobiology 1998; 66: 311-320.
23. Makino, N, Sugano M, Otsuka S, Hata T. Molecular mechanism of angiotensin II type I and type II receptors in cardiac hypertrophy of spontaneously hypertensive rats. Hypertension 1997; 30: 796-802.